Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , e8994064
Abstract
Background: Mitochondrial‐related pathways (MRPs) play a crucial role in cancer metabolism and progression; however, their prognostic value in breast cancer (BC) is still poorly understood. Methods: We integrated multiomics data to investigate the landscape of MRPs in BC. A mitochondria pathways‐associated signature (MPAS) was established using multimachine learning framework and interpreted by SHAP analysis across independent BC cohorts. Additionally, a series of functional experiments were employed to explore the role of RNA exonuclease 2 (REXO2) in BC cells. Results: MRPs are extensively activated in BC at multiomics level. MPAS demonstrates outstanding predictive performance across multiple BC cohorts, with high scores indicating poor clinical outcomes. Moreover, it was observed that high MPAS scores are closely associated with immunosuppressive states and inflammatory microenvironments. SHAP analysis identified REXO2 as a hub factor of MPAS. Cell‐based work confirmed that silencing REXO2 greatly inhibited cell proliferation and induced apoptosis in BC. Conclusions: Our proposed MPAS could effectively evaluate the prognosis and treatment response of BC patients, providing new reference for clinical decision‐making. Furthermore, REXO2 regulates cell proliferation and apoptosis, making it a promising potential therapeutic target for inhibiting BC progression.Keywords
This publication has 42 references indexed in Scilit:
- Oxidative Phosphorylation as an Emerging Target in Cancer TherapyClinical Cancer Research, 2018
- Expression of reactive species related genes is associated with patient survival in luminal B breast cancerFree Radical Biology and Medicine, 2018
- SCANPY: large-scale single-cell gene expression data analysisGenome Biology, 2018
- Breast Cancer Immunotherapy: Facts and HopesClinical Cancer Research, 2018
- MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative PhosphorylationCell Metabolism, 2017
- Parkin and mitophagy in cancerOncogene, 2016
- Mitochondria and CancerMolecular Cell, 2016
- REXO2 Is an Oligoribonuclease Active in Human MitochondriaPLOS ONE, 2013
- The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosomeExperimental Cell Research, 2012
- Regulation of the Apaf-1–caspase-9 apoptosomeJournal of Cell Science, 2010